Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX)
CUSIP: 74365A309
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 80,361,978
- Total 13F shares
- 8,821,889
- Share change
- +4,732,186
- Total reported value
- $39,349,366
- Put/Call ratio
- 133%
- Price per share
- $4.46
- Number of holders
- 36
- Value change
- +$21,195,496
- Number of buys
- 26
- Number of sells
- 7
Quarterly Holders Quick Answers
What is CUSIP 74365A309?
CUSIP 74365A309 identifies PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74365A309:
Top shareholders of PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Burrage Capital Management LLC |
13F
|
Company |
3.1%
|
2,470,332
|
$8,967,000 | — | 31 Dec 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.61%
|
488,634
|
$1,774,000 | — | 31 Dec 2020 | |
| Psagot Value Holdings Ltd. |
13F
|
Company |
0.59%
|
470,255
|
$1,707,000 | — | 31 Dec 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
212,591
|
$772,000 | — | 31 Dec 2020 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.19%
|
150,000
|
$544,000 | — | 31 Dec 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.08%
|
66,631
|
$242,000 | — | 31 Dec 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
55,589
|
$202,000 | — | 31 Dec 2020 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.06%
|
50,280
|
$183,000 | — | 31 Dec 2020 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.03%
|
23,353
|
$85,000 | — | 31 Dec 2020 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
22,218
|
$81,000 | — | 31 Dec 2020 | |
| CAPSTONE INVESTMENT ADVISORS, LLC |
13F
|
Company |
0.03%
|
22,152
|
$80,000 | — | 31 Dec 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.03%
|
22,068
|
$80,000 | — | 31 Dec 2020 | |
| WOLVERINE TRADING, LLC |
13F
|
Company |
0.01%
|
10,878
|
$38,000 | — | 31 Dec 2020 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.01%
|
10,042
|
$36,000 | — | 31 Dec 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.01%
|
5,761
|
$21,000 | — | 31 Dec 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2,100
|
$8,000 | — | 31 Dec 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,197
|
$5,000 | — | 31 Dec 2020 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
1,000
|
$4,000 | — | 31 Dec 2020 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
1,100
|
$3,993 | — | 31 Dec 2020 | |
| Gemmer Asset Management LLC |
13F
|
Company |
0%
|
800
|
$3,000 | — | 31 Dec 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
500
|
$2,000 | — | 31 Dec 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
222
|
$1,000 | — | 31 Dec 2020 |
Institutional Holders of Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) as of Q1 2021
As of 31 Mar 2021,
Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,821,889 shares.
The largest 10 holders included
Psagot Investment House Ltd., Burrage Capital Management LLC, DAFNA Capital Management LLC, RENAISSANCE TECHNOLOGIES LLC, UBS OCONNOR LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Phoenix Holdings Ltd., SUSQUEHANNA INTERNATIONAL GROUP, LLP, D.A. DAVIDSON & CO., and ADVISOR GROUP HOLDINGS, INC..
This page lists
36
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
22
Q1 2021 holders
36
Holder diff
14
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.